Delivery Order SPE2DB24D1104-SPE2DB25FXTX3

Award Date 10/29/24
Potential Completion Date 10/30/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,703.00 firm fixed-price delivery order contract is for the supply of NAFTIFINE HCL 1% CREAM 90GM. The contract has an ultimate completion date of January 3, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,319.28 firm fixed price delivery order is for the supply of NAFTIFINE HCL 1% CREAM 60GM, a pharmaceutical product. The contract has an ultimate completion date of February 25, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The provided information details a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,389.08 firm fixed-price delivery order contract is for the provision of NAFTIFINE HCL 1% cream, a pharmaceutical product. This contract appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,738.15 firm fixed-price delivery order is for the supply of 4562275506 - NAFTIFINE HCL 1% CREAM 60GM, with an ultimate completion date of September 25, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,591.47 delivery order contract is for the supply of Naftifine HCL 1% Cream, a topical antifungal medication, with a period of performance through November 2024. The contract is a Firm Fixed Price (FFP) agreement with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide Naftifine HCL 1% Cream 60GM to the Defense Logistics Agency (DLA). The Delivery Order contract, valued at $1,588.18, has a firm fixed price and runs through January 4, 2024. The contract was awarded on January 3, 2024, and there is no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NAFTIFINE HCL 1% CREAM 60GM, with a ceiling value of $1,166.53 and a period of performance through November 18, 2024. The contract was awarded on November 15, 2024 and is a Firm Fixed Price Delivery Order. This award is not designated with a set-aside. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,167.69 firm fixed price delivery order is for the supply of 4566149858 - NAFTIFINE HCL 2% CREAM 60GM. The contract has an ultimate completion date of October 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,875.18 Firm Fixed Price Delivery Order is for the supply of Naftifine HCL 1% Cream 60GM, with a period of performance through November 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,125.43 Firm Fixed Price delivery order contract is for the supply of Naftifine HCL 2% Gel, a pharmaceutical product. The contract has an ultimate completion date of December 30, 2024 and was awarded on December 27, 2024. No set-aside designation was used for this award. Amerisourcebergen holds a $999,999,999...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB25FXTX3
    Delivery Order

This federal contract award is for the delivery of Naftifine HCL 2% Cream, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,024.72 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider.

The contract is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.

Generated 1/28/25, 12:13 PM